-
Something wrong with this record ?
Sedation strategies for defibrillation threshold testing: safety outcomes with anaesthesiologist compared to proceduralist-directed sedation: an analysis from the SIMPLE study
RK. Sandhu, KK. Quadros, YY. Liu, M. Glikson, V. Kutyifa, P. Mabo, S. Hohnloser, G. O'Hara, L. VanErven, J. Neuzner, J. Kautzner, F. Gadler, X. Vinolas, U. Appl, SJ. Connolly, JS. Healey,
Language English Country England, Great Britain
Document type Journal Article, Randomized Controlled Trial
NLK
Free Medical Journals
from 1999 to 1 year ago
PubMed Central
from 2008
Open Access Digital Library
from 1999-01-01
Medline Complete (EBSCOhost)
from 1999-01-01
Oxford Journals Open Access Collection
from 1999-01-01
- MeSH
- Conscious Sedation * adverse effects methods MeSH
- Defibrillators, Implantable * MeSH
- Ventricular Fibrillation therapy MeSH
- Risk Assessment MeSH
- Hypnotics and Sedatives * administration & dosage adverse effects MeSH
- Prosthesis Implantation * adverse effects instrumentation methods MeSH
- Middle Aged MeSH
- Humans MeSH
- Death, Sudden, Cardiac etiology prevention & control MeSH
- Postoperative Complications * diagnosis epidemiology etiology MeSH
- Risk Factors MeSH
- Aged MeSH
- Outcome and Process Assessment, Health Care MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Randomized Controlled Trial MeSH
Aims: No standard practice exists with respect to anaesthesiologist-directed sedation (ADS) vs. sedation by proceduralist (PDS) for defibrillation threshold (DT) testing. We aimed to evaluate adverse events and safety outcomes with ADS vs. PDS for DT testing. Methods and results: A post hoc analysis of the Shockless Implant Evaluation (SIMPLE) study was performed among the 1242 patients who had DT testing (624 ADS and 618 PDS). We evaluated both intraoperative and in-hospital adverse composite events and two safety composite outcomes at 30-days of the main trial. Propensity score adjusted models were used to compute odds ratio (OR) and 95% confidence interval (CI) to evaluate the association between adverse and safety outcomes with method of sedation and independent predictors for use of ADS. Compared to PDS, patients who received ADS were younger (62 ± 12 years vs. 64 ± 12 years, P = 0.01), had lower ejection fraction (left ventricular ejection fraction 0.31 ± 13 vs. 0.33 ± 13, P = 0.03), were more likely to receive inhalational anaesthesia, propofol, or narcotics (P < 0.001, respectively) and receive an arterial line (43% vs. 8%, P = <0.0001). Independent predictors for ADS sedation were presence of coronary artery disease (OR 1.69, 95% CI 1.0-2.72; P = 0.03) and hypertrophic cardiomyopathy (OR 2.64, 95% CI 1.19-5.85; P = 0.02). Anaesthesiologist directed sedation had higher intraoperative adverse events (2.2% vs. 0.5%; OR 4.47, 95% CI 1.25-16.0; P = 0.02) and higher primary safety outcomes at 30 days (8.2% vs. 4.9%; OR 1.72 95% CI 1.06-2.80; P = 0.03) and no difference in other outcomes compared to PDS. Conclusion: Proceduralist-directed sedation is safe, however, this could be result of selection bias. Further research is needed.
Boston Scientific Minneapolis MN USA Boston Scientific Brussels Belgium
Centre Hospitalier Universitaire Rennes France
Hospital de Santa Creu i Sant Pau Barcelona Spain
Hungary Semmelweis Univ Sch Med Budapest Hungary
Institut Universitaire de Cardiologie et de Pneumologie de Québec QC Canada
Institute for Clinical and Experimental Medicine Prague Czech Republic
JW Goethe University Frankfurt Germany
Karolinska Institute Stockholm Sweden
Klinikum Kassel Kassel Germany
Leiden University Medical Center Leiden the Netherlands
Leviev Heart Center Sheba Medical Center Tel Hashomer Israel
Mazankowski Alberta Heart Institute University of Alberta 8440 112 Street 2C2 WMC Edmonton AB Canada
Population Health Research Institute McMaster University Hamilton ON Canada
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028394
- 003
- CZ-PrNML
- 005
- 20190815105319.0
- 007
- ta
- 008
- 190813s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/europace/euy114 $2 doi
- 035 __
- $a (PubMed)29878102
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Sandhu, Roopinder K $u Mazankowski Alberta Heart Institute, University of Alberta, 8440-112 Street, 2C2 WMC Edmonton, AB, Canada.
- 245 10
- $a Sedation strategies for defibrillation threshold testing: safety outcomes with anaesthesiologist compared to proceduralist-directed sedation: an analysis from the SIMPLE study / $c RK. Sandhu, KK. Quadros, YY. Liu, M. Glikson, V. Kutyifa, P. Mabo, S. Hohnloser, G. O'Hara, L. VanErven, J. Neuzner, J. Kautzner, F. Gadler, X. Vinolas, U. Appl, SJ. Connolly, JS. Healey,
- 520 9_
- $a Aims: No standard practice exists with respect to anaesthesiologist-directed sedation (ADS) vs. sedation by proceduralist (PDS) for defibrillation threshold (DT) testing. We aimed to evaluate adverse events and safety outcomes with ADS vs. PDS for DT testing. Methods and results: A post hoc analysis of the Shockless Implant Evaluation (SIMPLE) study was performed among the 1242 patients who had DT testing (624 ADS and 618 PDS). We evaluated both intraoperative and in-hospital adverse composite events and two safety composite outcomes at 30-days of the main trial. Propensity score adjusted models were used to compute odds ratio (OR) and 95% confidence interval (CI) to evaluate the association between adverse and safety outcomes with method of sedation and independent predictors for use of ADS. Compared to PDS, patients who received ADS were younger (62 ± 12 years vs. 64 ± 12 years, P = 0.01), had lower ejection fraction (left ventricular ejection fraction 0.31 ± 13 vs. 0.33 ± 13, P = 0.03), were more likely to receive inhalational anaesthesia, propofol, or narcotics (P < 0.001, respectively) and receive an arterial line (43% vs. 8%, P = <0.0001). Independent predictors for ADS sedation were presence of coronary artery disease (OR 1.69, 95% CI 1.0-2.72; P = 0.03) and hypertrophic cardiomyopathy (OR 2.64, 95% CI 1.19-5.85; P = 0.02). Anaesthesiologist directed sedation had higher intraoperative adverse events (2.2% vs. 0.5%; OR 4.47, 95% CI 1.25-16.0; P = 0.02) and higher primary safety outcomes at 30 days (8.2% vs. 4.9%; OR 1.72 95% CI 1.06-2.80; P = 0.03) and no difference in other outcomes compared to PDS. Conclusion: Proceduralist-directed sedation is safe, however, this could be result of selection bias. Further research is needed.
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a analgosedace $x škodlivé účinky $x metody $7 D016292
- 650 _2
- $a náhlá srdeční smrt $x etiologie $x prevence a kontrola $7 D016757
- 650 12
- $a defibrilátory implantabilní $7 D017147
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a hypnotika a sedativa $x aplikace a dávkování $x škodlivé účinky $7 D006993
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a výsledky a postupy - zhodnocení (zdravotní péče) $7 D010043
- 650 12
- $a pooperační komplikace $x diagnóza $x epidemiologie $x etiologie $7 D011183
- 650 12
- $a implantace protézy $x škodlivé účinky $x přístrojové vybavení $x metody $7 D019919
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a fibrilace komor $x terapie $7 D014693
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 700 1_
- $a Quadros, Kenneth K $u Mazankowski Alberta Heart Institute, University of Alberta, 8440-112 Street, 2C2 WMC Edmonton, AB, Canada.
- 700 1_
- $a Liu, Yan Yun $u Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
- 700 1_
- $a Glikson, Michael $u Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel.
- 700 1_
- $a Kutyifa, Valentina $u Hungary-Semmelweis Univ Sch Med, Budapest, Hungary.
- 700 1_
- $a Mabo, Phillipe $u Centre Hospitalier Universitaire, Rennes, France.
- 700 1_
- $a Hohnloser, Stefan $u JW Goethe University, Frankfurt, Germany.
- 700 1_
- $a O'Hara, Gilles $u Institut Universitaire de Cardiologie et de Pneumologie de Québec, QC, Canada.
- 700 1_
- $a VanErven, Liselot $u Leiden University Medical Center, Leiden, the Netherlands.
- 700 1_
- $a Neuzner, Jorg $u Klinikum Kassel, Kassel, Germany.
- 700 1_
- $a Kautzner, Josef $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Gadler, Frederik $u Karolinska Institute, Stockholm, Sweden.
- 700 1_
- $a Vinolas, Xavier $u Hospital de Santa Creu i Sant Pau, Barcelona, Spain.
- 700 1_
- $a Appl, Ursula $u Boston Scientific, Minneapolis, MN, USA. Boston Scientific, Brussels, Belgium.
- 700 1_
- $a Connolly, Stuart J $u Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
- 700 1_
- $a Healey, Jeff S $u Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
- 773 0_
- $w MED00149837 $t Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology $x 1532-2092 $g Roč. 20, č. 11 (2018), s. 1798-1803
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29878102 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190815105547 $b ABA008
- 999 __
- $a ok $b bmc $g 1433543 $s 1066854
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 20 $c 11 $d 1798-1803 $e 20181101 $i 1532-2092 $m Europace $n Europace $x MED00149837
- LZP __
- $a Pubmed-20190813